Orthopedic Regenerative Screening Toolkit: Patient Candidacy Criteria

Patient candidacy for regenerative orthopedic interventions depends heavily on baseline joint geometry, residual articular cartilage, and mechanical alignment. Clinicians should evaluate weight-bearing plain radiographs obtained within six months prior to procedural planning. Advanced imaging, such as non-contrast MRI, is recommended when assessing soft tissue integrity, subchondral bone marrow lesions, or meniscal tears.

Patients presenting with end-stage joint degeneration—such as Kellgren-Lawrence Grade IV osteoarthritis with severe bone-on-bone contact or severe angular deformity—generally demonstrate lower clinical response rates. Optimal candidates typically present with Grade II to III osteoarthritis or focal cartilage defects where joint space remains partially preserved.

Systemic inflammation and metabolic dysfunction directly impact the local cellular microenvironment and overall biological tissue response. Patients with uncontrolled diabetes mellitus (HbA1c > 8.0%), active metabolic syndrome, or severe autoimmune flares exhibit compromised healing capacity that may reduce treatment efficacy.

Lifestyle factors must be evaluated during initial intake. Active tobacco use, heavy alcohol consumption, and systemic immunosuppressive therapy represent significant metabolic headwinds. Modifiable risk factors should be optimized prior to scheduling cellular or acellular orthobiologic procedures.

Establishing clear contraindication protocols protects patient safety and avoids unnecessary procedural failures. Absolute contraindications include active systemic infection, localized infection at the targeted injection site, active hematologic malignancy, or ongoing systemic chemotherapy.

Relative contraindications require individualized clinical evaluation and potential modification of procedural timelines. These include recent systemic corticosteroid use (within 4–6 weeks), concurrent anticoagulant therapy requiring hold protocols, and severe uncorrected mechanical instability. Reviewing available biologic processing options alongside patient-specific lab profiles helps clinicians determine appropriate candidate readiness.

Standardized baseline functional scoring provides an objective foundation for tracking post-procedure outcomes. Practices should implement validated, region-specific patient-reported outcome measures (PROMs) such as KOOS for knees, HOOS for hips, or DASH for upper extremities during the initial consultation.

Managing patient expectations is equally critical. Candidate education must clearly communicate that biological therapies aim to support tissue homeostasis and functional improvement rather than deliver instantaneous structural restoration. Clear documentation of informed consent addressing realistic recovery timelines minimizes clinical misalignment.

A standardized screening workflow allows clinical support staff to pre-screen referrals before clinician review. Medical assistants or patient coordinators can collect required imaging, medication logs, and health history intake forms prior to the initial evaluation.

Integrating screening decision trees into the practice management system streamlines patient tracking, referral communication, and follow-up scheduling. Practices operating dedicated orthopedic service lines can review advanced workflow protocols and equipment integration options through our technologies resource library.